Home / Health / Natural Amino Acid May Cut Alzheimer's Risk, Study Finds
Natural Amino Acid May Cut Alzheimer's Risk, Study Finds
23 Nov
Summary
- Arginine, a natural amino acid, significantly reduces brain plaque.
- Oral arginine suppressed plaque formation in animal models.
- Arginine is safe, inexpensive, and could be a therapeutic option.
New research indicates that arginine, a naturally occurring amino acid, could potentially reduce the risk of Alzheimer's disease. Studies published in Neurochemistry International demonstrate that arginine effectively suppresses the formation of amyloid plaques, a key characteristic of Alzheimer's pathology in the brain. This discovery offers a potential new avenue for combating neurodegenerative diseases.
The research found that oral administration of arginine in animal models led to a significant decrease in amyloid beta aggregation and its associated toxicity. Furthermore, the treated animals showed improved performance in behavioral tests and reduced markers of neuroinflammation, suggesting a broader protective effect on brain health.
Researchers are optimistic about arginine's potential due to its established safety profile and low cost. This makes it a promising candidate for further investigation in clinical trials. However, scientists emphasize that extensive preclinical and clinical studies are still necessary to confirm these findings in humans and determine optimal dosing strategies.
